InMed Pharmaceuticals Inc. (NASDAQ:INM)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $2.06B
- Net income
- -$12.6M
- Net margin
- -0.6%
Little or no net debt.
- Total debt
- $0
- Cash
- $2.2M
- Debt / equity
- 0.00
Covers near-term obligations, without much room.
- Current assets
- $2.7M
- Current liabilities
- $2.0M
- Current ratio
- 1.37
Roughly cash-neutral.
- Operating cash flow
- -$10.1M
- Free cash flow
- -$10.1M
- FCF margin
- -0.5%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 4.4M
- Share growth (1y)
- 118.4%
- Cash runway
- 3 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
INM Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 2.06 B | 0.00 | 1.13 M | 1.12 M | 1.78 M | 1.26 M |
| Revenue Growth (YoY) | 115691.64 % | -100.00 % | 1.23 % | -11.43 % | 38.51 % | 7.59 % |
| Cost of Revenue | 1.75 B | 0.00 | 1.09 M | 716.96 K | 991.69 K | 1.09 M |
| Gross Profit | 306.94 M | 0.00 | 35.91 K | 403.16 K | 785.47 K | 175.63 K |
| SG&A Expense | 1.87 B | 1.74 M | 2.08 M | 1.53 M | 3.07 M | 1.33 M |
| R&D Expense | 567.89 M | 1.02 M | 865.31 K | 581.61 K | 153.54 K | 909.65 K |
| Operating Expenses | 2.95 M | 2.82 M | 2.95 M | 2.17 M | 3.22 M | 2.29 M |
| Operating Income | -3.21 M | -2.82 M | -2.91 M | -1.76 M | -2.44 M | -2.12 M |
| Pretax Income | -4.84 M | -2.79 M | -2.78 M | -1.73 M | -2.44 M | -2.12 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -5.08 M | -2.97 M | -2.78 M | -1.73 M | -2.44 M | -2.12 M |
| EPS (Basic) | -1.43 | -0.73 | -0.71 | -0.61 | -1.22 | -1.94 |
| EPS (Diluted) | -1.43 | -0.73 | -0.71 | -0.61 | -1.22 | -1.94 |
| Shares Outstanding | 4.37 M | 4.05 M | 3.95 M | 3.95 M | 2.00 M | 1.10 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.